Gut microbiota and the paradox of cancer immunotherapy.

Front Immunol
Authors
Abstract

It is recently shown that beneficial environmental microbes stimulate integrated immune and neuroendocrine factors throughout the body, consequently modulating regulatory T-lymphocyte phenotypes, maintaining systemic immune balance, and determining the fate of preneoplastic lesions toward regression while sustaining whole body good health. Stimulated by a gut microbiota-centric systemic homeostasis hypothesis, we set out to explore the influence of the gut microbiome to explain the paradoxical roles of regulatory T-lymphocytes in cancer development and growth. This paradigm shift places cancer prevention and treatment into a new broader context of holobiont engineering to cultivate a tumor-suppressive macroenvironment.

Year of Publication
2014
Journal
Front Immunol
Volume
5
Pages
157
Date Published
2014
URL
DOI
10.3389/fimmu.2014.00157
PubMed ID
24778636
PubMed Central ID
PMC3985000
Links
Grant list
P30 ES002109 / ES / NIEHS NIH HHS / United States
R01 CA108854 / CA / NCI NIH HHS / United States
U01 CA164337 / CA / NCI NIH HHS / United States